Difficulties with vaccination in the EU countries could bring large losses in the coming months. A delay in reopening European businesses could result in losses of $ 65 billion to $ 100 billion.
This estimate is given by the American business publication Bloomberg. It refers to the views of investors concerned about the situation with the coronavirus pandemic in Europe. For example, Sima Shah, an analyst at Principal Global Investors, notes the "sluggish" rate of vaccination. According to the publication, in the European Union, on average, 8.96 vaccinations were made with at least one component of a two-component vaccine per 100 inhabitants, while in the USA this figure reaches 26.48, in the UK - up to 32.6, and in Israel - up to 95. 35.
The publication notes that European funds have been recording capital outflows for the third week in a row. Bank of America spokesman Athanasios Vamvakidis explained that difficulties with vaccinations in the European Union in the spring could result in large losses for the tourism industry after the start of the new season.
Earlier, "Profile" wrote that the Austrian authorities decided as a precautionary measure to suspend the use of a batch of vaccine against the AstraZeneca coronavirus. This happened due to the death of a woman who took this drug. Earlier it was reported that 41 people died in Austria after being vaccinated against coronavirus by the Pfizer-BioNTech consortium, but a direct link with vaccination has not been established.